Synopsis

Source of validity: Scientific
Rating (out of 5): 3

1,3, N-Dipropyl-7-Propargylxanthine is a synthetic compound known primarily as a potent and selective adenosine A2A receptor antagonist. Its mechanism of action is closely related to caffeine, which is also an adenosine receptor antagonist and widely recognized for its cognitive-enhancing properties, especially in terms of alertness and concentration. There is substantial preclinical research indicating that antagonism of adenosine receptors can enhance dopaminergic and glutamatergic neurotransmission, resulting in improved cognitive performance, including attention and concentration, in animal models. However, direct clinical evidence in humans specifically for 1,3, N-Dipropyl-7-Propargylxanthine is limited. Most studies have been conducted in laboratory settings using animals or in vitro systems. Still, the broader class of adenosine receptor antagonists, to which this compound belongs, has been shown in human studies (with caffeine as the best-known example) to support alertness and concentration. Therefore, while the rationale for its use in supporting concentration is scientifically plausible, and the ingredient is employed in research settings for this purpose, robust clinical trials in humans are lacking, resulting in a moderate evidence rating.

More about DMPX
More about Concentration (poor)

Other ingredients used for Concentration (poor)

Other health conditions supported by DMPX

Products containing DMPX